What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News 4D Molecular Therapeutics’ 4D-110 receives FDA orphan drug designation for choroideremia 4D Molecular Therapeutics (4DMT), a prominent California-based gene therapy firm, has achieved a significant milestone with the US… bypharmanewsdailyNovember 17, 2018
